2022
DOI: 10.3390/biology11010122
|View full text |Cite
|
Sign up to set email alerts
|

Stem Cell Studies in Cardiovascular Biology and Medicine: A Possible Key Role of Macrophages

Abstract: Stem cells are used in cardiovascular biology and biomedicine, and research in this field is expanding. Two types of stem cells have been used in research: induced pluripotent and somatic stem cells. Stem cell research in cardiovascular medicine has developed rapidly following the discovery of different types of stem cells. Induced pluripotent stem cells (iPSCs) possess potent differentiation ability, unlike somatic stem cells, and have been postulated for a long time. However, differentiating into adult-type … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 124 publications
(141 reference statements)
0
4
0
Order By: Relevance
“…The ACE2/Ang 1-7)/MasR axis plays an important role in the biology of vasculogenic progenitor cells, hematopoietic stem cells, cardiomyocytes and dental stem cells [10,24,25]. Ang (1-7) improves pancreatic β-cell function and long-term Ang (1-7) administration in vivo affects insulin secretion from islets [26].…”
Section: Discussionmentioning
confidence: 99%
“…The ACE2/Ang 1-7)/MasR axis plays an important role in the biology of vasculogenic progenitor cells, hematopoietic stem cells, cardiomyocytes and dental stem cells [10,24,25]. Ang (1-7) improves pancreatic β-cell function and long-term Ang (1-7) administration in vivo affects insulin secretion from islets [26].…”
Section: Discussionmentioning
confidence: 99%
“…This mechanism has been deemed responsible for the restorative processes associated with cell therapy, including positive myocardial remodelling, cardioprotection, neovascularization, and neo-myogenesis 85 ( Figure 2 ). The now emerging paradigm is that exogenous cells may exert most of their beneficial actions via an immune-modulation, in particular recent studies have highlighted the emerging role of macrophages in triggering cell regeneration 28 , 86 The above considerations bring into question the contraposition of autologous vs allogenic stem cell therapy. Most of the studies seem to agree that if the paracrine effect is what a cell therapy approach has to achieve, then allogenic cells are the strategy to prefer.…”
Section: Gaps In Evidencementioning
confidence: 99%
“…For example, many in vitro disease models have been established [ 15 , 16 , 17 ] since induced pluripotent stem cells (iPSCs) were first developed by Takahashi and Yamanaka [ 18 , 19 ]. However, the immaturity of cardiomyocytes derived from iPSCs has been reported [ 20 , 21 ]. This is one of the problems associated with iPSC-derived cardiomyocytes, with symptoms often appearing after birth.…”
Section: Introductionmentioning
confidence: 99%